Investor Presentation First Nine Months of 2023

116 Investor presentation First nine months of 2023 Insulin market size and volume share of growth and market share in International Operations Total Insulin market share and market size (DKK billion) Long- Acting 40% 51% Fast- acting 58% 15 Premix 81% 8 48% Human 7 Novo Nordisk 28 Competitors Market growth1 A Market share 80% 57 -10.2% +0.2% Insulin volume: Market share Novo NordiskⓇ 10% 7% 60% -7.9% +1.5% 48% 4% 40% 1% -3% -5.0% -1.4% -2% 20% -5% -18.9% +1.4% -6% 0% -8% Aug Aug -18.8% +0.3% 2020 2023 NN market share -Market growth (Right Axis) NN growth (Right Axis) 1Market growth is YTD current vs YTD previous year Source: IQVIA, Aug 2023, LHS graph - Value, RHS Graph - Volume, MAT, all countries; Share of growth not depicted due to too high numbers; NN: Novo Nordisk; Market values are based on the list prices

View entire presentation